US11512141B2

Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer …

University of Texas System

Abstract

Provided herein are anti-FGL2 monoclonal antibodies. Further provided herein are methods to reverse suppressive immune mechanisms, such as for the treatment of cancer or infectious diseases.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Shulin Li
Priority date: May 05, 2017
Filing date: May 07, 2018
Grant date: November 29, 2022
Publication date: November 29, 2022
Language: en
PDF source: https://patentimages.storage.googleapis.com/1b/e5/67/6e55f631ca46c0/US11512141B2.pdf
Metadata fetched: August 29, 2026 00:30